2010 Hemostasis Gordon Research Conference and/or Gordon Research Seminar
2010 Hemostasis Gordon Research Conference and/or Gordon Research Seminar
批准号:
7911112
负责人:
Nigel Mackman
金额:
$1.0万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2011-03-31
关键词:
AnticoagulantsAreaBiologyBlood ClotBlood PlateletsBlood coagulationCause of DeathCoagulation ProcessConsultationsDiagnosisDisabled PersonsDisciplineDiseaseFibrinGoalsHemostatic functionHourIndividualInternationalLocationMaineMinority GroupsNew HampshireParticipantPathway interactionsPostdoctoral FellowResearchScienceSenior ScientistThrombosisTimeUnderrepresented MinorityWomanWritingcollegedesigngraduate studentimprovedmeetingsplanetary Atmospherepostersprogramspublic health relevancesymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
This application seeks partial support for the bi-annual Gordon Conference (GRC) on Hemostasis and/or its preceding Gordon Research Seminar (GRS). The broad and long term goal of the conference is to increase our understanding of the fundamental mechanisms that regulate formation of a platelet-fibrin clot. The last two highly successful Hemostasis GRCs were held at Colby College, Maine in 2006 and Waterville Valley, New Hampshire in 2008. The next conference will be held on July 25th - July 30th 2010 at Waterville Valley Conference Center, Waterville Valley, New Hampshire. The 2008 found this venue to be a comfortable and inviting location. Always oversubscribed, well-attended, and highly evaluated by its participants, the GRC on Hemostasis for 2010 will be comprised of nine 3 hour sessions that will be held in the allotted morning and evening time slots. Poster presentations will be held before dinner on four of the five days. These are always very well-attended, and provide a dedicated, informal forum for interaction between junior and more senior scientists in the field. A Hot Topics Session, quickly becoming a tradition at our GRC, is planned for Wednesday night. The specific aims of this meeting will be to convene 39 Speakers and Discussion Leaders that represent critical areas of hemostasis research with a total of approx. 150 participants for a five day conference in a relatively isolated setting. The Speakers and Discussion Leaders have been carefully chosen by the Chair and Vice-Chair after extensive, careful consideration and consultation with former Chairs of the 2004, 2006, and 2008 Hemostasis GRC. Of these, we already have written acceptances from all participants. We have also made a concerted effort to achieve appropriate representation of women, racial and ethnic minorities, persons with disabilities, and other individuals from groups that have traditionally been underrepresented in science as Speakers and Discussion Leaders. Our current list of invited speakers and discussion leaders already includes 8 women, and we expect to increase the representation of women among our speakers, as well as including underrepresented minorities, in the Hot Topics session. The program is designed to provide an invigorating meeting covering a range of timely disciplines in the fields of thrombosis and hemostasis. A two day Gordon Research Seminar will precede the meeting and will allow post-docs and graduate students to interact in a more relaxed atmosphere. The significance of this application is that the Hemostasis GRC is widely considered to be the premiere small meeting on the topics of blood coagulation, platelet biology, and anticoagulant pathways, enjoying both national and international reputation. First organized by hemostasis pioneers Earl W. Davie and Oscar Ratnoff in 1973. The healthy relatedness of this application is that thrombosis is the leading cause of death in the US and there is an urgent need for improving diagnosis and treatment of this devastating disease. PUBLIC HEALTH RELEVANCE: Thrombosis is the leading cause of death in the US and there is an urgent need for improving diagnosis and treatment of this devastating disease. The goal of the conference is to increase our understanding of the fundamental mechanisms that regulate formation of a blood clot. The Hemostasis GRC is widely considered to be the premiere small meeting, on the topics of blood coagulation, platelet biology, and anticoagulant pathways, enjoying both national and international reputation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tissue factor-dependent coagulation in thrombosis and immune responses
-
批准号:10558720
-
项目类别:
-
资助金额:$93.3万
-
财政年份:2021
-
负责人:Nigel Mackman
-
依托单位:
Role of the Thrombin PAR-1 Pathway in Viral Infection
-
批准号:9380482
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2013
-
负责人:Nigel Mackman
-
依托单位:
Role of the Thrombin PAR-1 Pathway in Viral Infection
-
批准号:8558940
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2013
-
负责人:Nigel Mackman
-
依托单位:
Role of the Thrombin PAR-1 Pathway in Viral Infection
-
批准号:8891487
-
项目类别:
-
资助金额:$37.43万
-
财政年份:2013
-
负责人:Nigel Mackman
-
依托单位:
Role of the Thrombin PAR-1 Pathway in Viral Infection
-
批准号:8706957
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2013
-
负责人:Nigel Mackman
-
依托单位:
ROLE OF TISSUE FACTOR IN HEMOSTASIS & THROMBOSIS
-
批准号:8147401
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2010
-
负责人:Nigel Mackman
-
依托单位:
ROLE OF TISSUE FACTOR IN HEMOSTASIS & THROMBOSIS
-
批准号:7667048
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2009
-
负责人:Nigel Mackman
-
依托单位:
Role of PAR-1 and PAR-2 in Cardiac Remodeling
-
批准号:7891220
-
项目类别:
-
资助金额:$37.11万
-
财政年份:2007
-
负责人:Nigel Mackman
-
依托单位:
Role of PAR-1 and PAR-2 in Cardiac Remodeling
-
批准号:7487314
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2007
-
负责人:Nigel Mackman
-
依托单位:
Role of PAR-1 and PAR-2 in Cardiac Remodeling
-
批准号:7666964
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2007
-
负责人:Nigel Mackman
-
依托单位:
Role of Tissue Factor in Atherosclerosis
-
批准号:7432440
-
项目类别:
-
资助金额:$46.21万
-
财政年份:2007
-
负责人:Nigel Mackman
-
依托单位:
Role of PAR-1 and PAR-2 in Cardiac Remodeling
-
批准号:7322258
-
项目类别:
-
资助金额:$38.21万
-
财政年份:2007
-
负责人:Nigel Mackman
-
依托单位:
Role of Tissue Factor in Atherosclerosis
-
批准号:7237997
-
项目类别:
-
资助金额:$40.81万
-
财政年份:2006
-
负责人:Nigel Mackman
-
依托单位:
Role of Tissue Factor in Atherosclerosis
-
批准号:7105006
-
项目类别:
-
资助金额:$39.62万
-
财政年份:2005
-
负责人:Nigel Mackman
-
依托单位:
Role of Tissue Factor in Atherosclerosis
-
批准号:6859757
-
项目类别:
-
资助金额:$38.46万
-
财政年份:2004
-
负责人:Nigel Mackman
-
依托单位:
Thrombin-PAR-1 Signaling in Cardiac I/R Injury
-
批准号:6798196
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2002
-
负责人:Nigel Mackman
-
依托单位:
Thrombin-PAR-1 Signaling in Cardiac I/R Injury
-
批准号:6925504
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2002
-
负责人:Nigel Mackman
-
依托单位:
Thrombin-PAR-1 Signaling in Cardiac I/R Injury
-
批准号:6653192
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2002
-
负责人:Nigel Mackman
-
依托单位:
Thrombin-PAR-1 Signaling in Cardiac I/R Injury
-
批准号:6521683
-
项目类别:
-
资助金额:$39.91万
-
财政年份:2002
-
负责人:Nigel Mackman
-
依托单位:
BLOOD COAGULATION & FIBRINOLYSIS
-
批准号:6153469
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2000
-
负责人:Nigel Mackman
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: